Eip Pharma Inc

This study tests a drug called neflamapimod to see if it can help people recover better after a moderate to severe stroke. Researchers will measure improvements in movement, balance, and daily activities over 12 weeks. The study involves 90 adults aged 45 and older who had a stro…

This early study tests a drug called neflamapimod in 20 people with a rare brain condition that slowly destroys the ability to speak (primary progressive aphasia). The main goal is to check safety and see if the drug can improve language symptoms. Participants take the drug for s…